A detailed history of American Century Companies Inc transactions in Catalent, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 44,232 shares of CTLT stock, worth $2.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,232
Previous 41,069 7.7%
Holding current value
$2.69 Million
Previous $2.31 Million 16.02%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$56.16 - $60.96 $177,634 - $192,816
3,163 Added 7.7%
44,232 $2.68 Million
Q2 2024

Aug 07, 2024

BUY
$53.58 - $57.02 $283,866 - $302,091
5,298 Added 14.81%
41,069 $2.31 Million
Q1 2024

May 14, 2024

BUY
$42.56 - $59.82 $396,403 - $557,163
9,314 Added 35.2%
35,771 $2.02 Million
Q4 2023

Feb 13, 2024

BUY
$32.18 - $46.57 $851,386 - $1.23 Million
26,457 New
26,457 $1.19 Million
Q3 2023

Nov 13, 2023

BUY
$44.2 - $50.2 $68,289 - $77,559
1,545 Added 9.66%
17,533 $798,000
Q2 2023

Aug 14, 2023

SELL
$31.86 - $67.26 $140 Million - $295 Million
-4,380,243 Reduced 99.64%
15,988 $693,000
Q1 2023

May 11, 2023

BUY
$45.44 - $74.26 $11.5 Million - $18.8 Million
253,646 Added 6.12%
4,396,231 $289 Million
Q4 2022

Feb 13, 2023

BUY
$41.39 - $81.0 $43.5 Million - $85.1 Million
1,051,160 Added 34.0%
4,142,585 $186 Million
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $34.5 Million - $54 Million
-477,166 Reduced 13.37%
3,091,425 $224 Million
Q2 2022

Aug 12, 2022

BUY
$87.2 - $114.05 $142 Million - $185 Million
1,624,464 Added 83.56%
3,568,591 $383 Million
Q1 2022

May 11, 2022

SELL
$94.19 - $124.49 $4.82 Million - $6.37 Million
-51,141 Reduced 2.56%
1,944,127 $216 Million
Q4 2021

Feb 07, 2022

SELL
$119.57 - $139.07 $44.2 Million - $51.4 Million
-369,822 Reduced 15.64%
1,995,268 $255 Million
Q3 2021

Nov 10, 2021

SELL
$109.17 - $142.35 $424,452 - $553,456
-3,888 Reduced 0.16%
2,365,090 $315 Million
Q2 2021

Aug 05, 2021

SELL
$100.34 - $115.69 $9.04 Million - $10.4 Million
-90,118 Reduced 3.66%
2,368,978 $256 Million
Q1 2021

May 14, 2021

BUY
$101.51 - $125.27 $281,385 - $347,248
2,772 Added 0.11%
2,459,096 $259 Million
Q4 2020

Feb 12, 2021

SELL
$85.88 - $105.36 $98.5 Million - $121 Million
-1,146,476 Reduced 31.82%
2,456,324 $256 Million
Q3 2020

Nov 13, 2020

SELL
$72.74 - $92.5 $10.7 Million - $13.6 Million
-146,802 Reduced 3.92%
3,602,800 $309 Million
Q2 2020

Aug 13, 2020

BUY
$48.02 - $79.04 $6.54 Million - $10.8 Million
136,116 Added 3.77%
3,749,602 $275 Million
Q1 2020

May 14, 2020

SELL
$36.95 - $62.95 $9.49 Million - $16.2 Million
-256,911 Reduced 6.64%
3,613,486 $188 Million
Q4 2019

Feb 12, 2020

BUY
$47.06 - $56.64 $29.6 Million - $35.6 Million
629,268 Added 19.42%
3,870,397 $218 Million
Q3 2019

Nov 13, 2019

SELL
$47.45 - $58.05 $3.62 Million - $4.43 Million
-76,331 Reduced 2.3%
3,241,129 $154 Million
Q2 2019

Aug 14, 2019

BUY
$39.26 - $54.21 $36.9 Million - $51 Million
939,940 Added 39.53%
3,317,460 $180 Million
Q1 2019

May 14, 2019

BUY
$29.84 - $43.92 $61.8 Million - $90.9 Million
2,070,583 Added 674.6%
2,377,520 $0
Q4 2018

Feb 13, 2019

BUY
$29.95 - $46.34 $1.6 Million - $2.48 Million
53,579 Added 21.15%
306,937 $9.57 Million
Q3 2018

Nov 02, 2018

SELL
$40.12 - $45.55 $112 Million - $128 Million
-2,799,157 Reduced 91.7%
253,358 $11.5 Million
Q2 2018

Aug 08, 2018

BUY
$38.72 - $42.52 $7.12 Million - $7.82 Million
183,880 Added 6.41%
3,052,515 $128 Million
Q1 2018

May 03, 2018

BUY
$39.4 - $47.39 $9.34 Million - $11.2 Million
236,992 Added 9.01%
2,868,635 $118 Million
Q4 2017

Feb 02, 2018

BUY
$37.27 - $43.02 $86.6 Million - $100 Million
2,323,971 Added 755.34%
2,631,643 $108 Million
Q3 2017

Nov 01, 2017

BUY
$33.75 - $41.67 $10.4 Million - $12.8 Million
307,672
307,672 $12.3 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.